PHS
XLNX

PFM Health Sciences’s Xilinx Inc XLNX Stock Holding History

PFM Health Sciences’s Portfolio XLNX Stock Details XLNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-124,677
Closed -$9.72M – 91
2020
Q1 		$9.72M Buy
+124,677
New +$10.9M 0.8% 42

Other funds holding XLNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

PFM Health Sciences's XLNX Position: Q2 2020 in Review

PFM Health Sciences sold out of Xilinx Inc (XLNX) in Q2 2020, closing a stake of 124,677 shares — an estimated $9.72M sold.

PFM Health Sciences first reported a position in XLNX in Q1 2020 and held it in 1 quarter. The position peaked at $9.72M in Q1 2020. 759 funds tracked by Wall St. Rank hold XLNX as of Q2 2020.

  • PFM Health Sciences reported no remaining Xilinx Inc position as of Q2 2020 after selling out during the quarter.
  • PFM Health Sciences sold 124,677 Xilinx Inc shares in Q2 2020, an estimated $9.72M.
  • PFM Health Sciences first reported a position in Xilinx Inc in Q1 2020 and held it in 1 quarter.
  • PFM Health Sciences's Xilinx Inc position peaked at $9.72M in Q1 2020.
  • 759 funds tracked by Wall St. Rank held Xilinx Inc as of Q2 2020.

Based on PFM Health Sciences's 13F filing for Q2 2020, filed 14 Aug 2020.